Making it Work Axis Consulting looks to double headcount as demand surges for new drug evaluationsThe Dublin-based firm assists pharmaceutical companies with the regulatory scrutiny drugs must endure to get onto the market
Stock Take Bank of Ireland: Manufacturing faces sluggish year as headwinds pick upIreland is outperforming Europe but a ‘wait and see’ approach will guide the rest of an uncertain year
Pharma EU regulation warding off life science investment – IDA chiefThe rules are the first major overhaul of the EU’s medicines regulations in 20 years, which aim to make access to medicines more secure and affordable
Pharma US lawmakers told WuXi sent intellectual property to ChinaPharma giant - which recently pumped $348 million into a dormant Irish entity - has been named a ‘company of concern’ by US lawmakers
Companies Chinese pharma giant pumps $350m into dormant Irish entityWuxi AppTec was recently named as a ‘company of concern’ by US lawmakers over alleged links to the Chinese military
Pharma AstraZeneca to buy Fusion Pharma for $2.4bnDeal marks a return to Astra chief Pascal Soriot’s core focus on oncology
Companies Top talent, not low tax, driving Bristol Myers Squibb’s Irish investment, executive saysPharmaceutical giant is hiring 350 new staff in Ireland as part of $400m injection which will make Dublin office more central to global operations
News Contracting pharma sector drags GDP down by 3.2 per centAll other sectors of the economy showed modest growth, according to new figures
Companies Waterford-based Suir Engineering to add 200 jobs as sales soarThe Irish mechanical and electrical engineering firm works with clients in the pharma, life sciences and data centre sectors
Pharma Uniphar profits climb 27 per cent on the back of booming supply chain and pharma growthThe pharma company reported over 34 per cent growth in its supply chain, retail and pharma wings, with more modest growth in its medtech division
Pharma Icon plans yearly $500m M&A spree on foot of bumper resultsDublin-headquartered company posted full-year revenues of more than $8.1 billion for 2023, which was up 5 per cent on the previous year
Stock Take Icon targets $500m in merger and acquisition deals as shares soar to record levelsThe Irish-headquartered contract research giant is now valued at close to $26bn after its shares surged 40 per cent in the last year
Companies Chanelle Pharma profits fall more than 40 per cent ahead of Exponent dealSale volumes had increased 5 per cent but profits dropped as rising interest rates hit the holding company’s bottom line
Pharma Bristol Myers Squibb to invest $400 million in Dublin campusThe investment will lead to the creation of 350 jobs by 2026, Bristol Myers Squibb said
Companies Icon plc announces $500m share buyback programme after posting record profits for 2023The Irish contract research company is forecasting a further double-digit increase in profits for 2024 as its order book continues to expand
Pharma Bristol Myers Squibb to appeal High Court ruling striking down patent on $12bn drugCourt recently invalidated the patent associated with Eliquis, the US pharma giants drug to reduce blood clots
Companies ‘I’m off to play golf with my wife’ – Chanelle founder Michael Burke on €300m saleThe Galway native said almost 30 bidders tabled an offer for his company over a sales process that lasted almost two years
Companies Galway-based Chanelle Pharma sold to British private equity firm ExponentThe Loughrea-headquartered company employs over 700 staff and produces generic pharmaceuticals for animal and human health
The Big Interview Big Interview: APC pharma founder Mark Barrett on learning from rugby and NasaAPC and VLE work with eight of the top 10 pharmaceutical companies globally, as well as a “myriad” of smaller companies in the sector
Pharma Novo becomes second ever European firm to breach $500bn market value Novo Nordisk shares have gained 60 per cent in the past year, fuelled by surging demand for Ozempic and Wegovy